Literature DB >> 2510588

Positron emission tomography in manganese intoxication.

E C Wolters1, C C Huang, C Clark, R F Peppard, J Okada, N S Chu, M J Adam, T J Ruth, D Li, D B Calne.   

Abstract

We employed 6-fluorodopa to study the integrity of the nigrostriatal dopaminergic projection by positron emission tomography in 4 subjects with clinical features of mild parkinsonism caused by exposure to manganese. The 6-fluorodopa scans were normal. This finding suggests that in early manganism sufficient to cause parkinsonian deficits, damage may occur in pathways postsynaptic to the nigrostriatal system, probably involving striatal or pallidal neurons. Fluorodeoxyglucose scans showed decreased cortical glucose metabolism, the significance of which is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510588     DOI: 10.1002/ana.410260510

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  24 in total

Review 1.  Neuroimaging biomarkers for Parkinson disease: facts and fantasy.

Authors:  Joel S Perlmutter; Scott A Norris
Journal:  Ann Neurol       Date:  2014-11-07       Impact factor: 10.422

Review 2.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

3.  Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism.

Authors:  Tomás R Guilarte; Neal C Burton; Jennifer L McGlothan; Tatyana Verina; Yun Zhou; Mohab Alexander; Luu Pham; Michael Griswold; Dean F Wong; Tore Syversen; Jay S Schneider
Journal:  J Neurochem       Date:  2008-09-20       Impact factor: 5.372

Review 4.  Are there common biochemical and molecular mechanisms controlling manganism and parkisonism.

Authors:  Jerome A Roth
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

5.  Age-dependent susceptibility to manganese-induced neurological dysfunction.

Authors:  Julie A Moreno; Elizabeth C Yeomans; Karin M Streifel; Bryan L Brattin; Robert J Taylor; Ronald B Tjalkens
Journal:  Toxicol Sci       Date:  2009-10-07       Impact factor: 4.849

6.  Neuromythology of Manganism.

Authors:  Kristin M Andruska; And Brad A Racette
Journal:  Curr Epidemiol Rep       Date:  2015-06

7.  Prolactin levels in manganese-exposed male welders.

Authors:  Engin Tutkun; Sedat Abuşoğlu; Hinç Yılmaz; Meşide Gündüzöz; Nilgün Gıynas; Ceylan Demir Bal; Ali Ünlü
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

8.  Pathophysiology of manganese-associated neurotoxicity.

Authors:  Brad A Racette; Michael Aschner; Tomas R Guilarte; Ulrike Dydak; Susan R Criswell; Wei Zheng
Journal:  Neurotoxicology       Date:  2011-12-21       Impact factor: 4.294

9.  Occupational neurotoxic diseases in taiwan.

Authors:  Chi-Hung Liu; Chu-Yun Huang; Chin-Chang Huang
Journal:  Saf Health Work       Date:  2012-11-30

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.